[1]陈郑,钟岱晔,冯佳梅.中医药治疗乳腺癌化疗后不良反应的研究进展[J].西部中医药,2026,39(07):147-152.[doi:10.12174/j.issn.2096-9600.2026.07.28]
　CHEN Zheng,ZHONG Daiye,FENG Jiamei.Research Progress of TCM in the Treatment of Adverse Reactions Caused by Chemotherapy for Breast Cancer[J].Western Journal of Traditional Chinese Medicine,2026,39(07):147-152.[doi:10.12174/j.issn.2096-9600.2026.07.28]
点击复制

中医药治疗乳腺癌化疗后不良反应的研究进展()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
39
期数:
2026年07期
页码:
147-152
栏目:
研究进展
出版日期:
2026-07-12

文章信息/Info

Title:
Research Progress of TCM in the Treatment of Adverse Reactions Caused by Chemotherapy for Breast Cancer
作者:
陈郑, 钟岱晔, 冯佳梅
上海中医药大学附属曙光医院，上海 201203
Author(s):
CHEN Zheng, ZHONG Daiye, FENG Jiamei
Shuguang Hospital Affiliated to Shanghai University of TCM, Shanghai 201203, China
关键词:
乳腺癌术后; 化疗; 不良反应; 中医药治疗
Keywords:
after surgery for breast cancer; chemotherapy; adverse reactions; TCM therapy
分类号:
R273
DOI:
10.12174/j.issn.2096-9600.2026.07.28
文献标志码:
A
摘要:
从中医药防治乳腺癌化疗后常见不良反应入手，梳理并探讨中医药干预乳腺癌化疗后不良反应的最新研究进展。发现：中医药可有效改善化疗所致骨髓抑制，在缓解化疗相关性胃肠道反应方面优势显著；对癌因性疲乏及睡眠障碍具有良好调控作用，同时可减轻蒽环类化疗药物所致心脏毒性、发挥对心肌的保护作用。此外，中医药具有多靶点、整体性调节的干预特点，在提升患者化疗耐受性、改善生存质量方面具备综合临床优势；但目前仍存在作用机制研究不够深入、统一标准化诊疗方案缺失等问题，有待后续进一步挖掘与完善。
Abstract:
Starting from the prevention and treatment of common adverse reactions after chemotherapy for breast cancer with traditional Chinese medicine, this paper reviews and discusses the latest research progress in TCM interventions for chemotherapy-induced adverse reactions in breast cancer. It has been found that TCM can effectively ameliorate chemotherapy-induced bone marrow suppression and has significant advantages in alleviating chemotherapy-related gastrointestinal reactions. It also exerts favorable regulatory effects on cancer-related fatigue and sleep disorders, while reducing the cardiotoxicity induced by anthracycline-based chemotherapeutic agents and exerting a protective effect on the myocardium. In addition, TCM has the characteristics of multi-target and holistic regulation, offering comprehensive clinical advantages in improving patients’ chemotherapy tolerance and quality of life. However, there are still problems such as insufficiently in-depth research on the mechanisms of action and the lack of standardized diagnosis and treatment protocols, which require further exploration and improvement in the future.

相似文献/References:

[1]李晶,刘小军,赵达△.康莱特软胶囊联合化疗治疗晚期卵巢癌的临床研究[J].西部中医药,2013,26(01):1.
　LI Jing,LIU Xiaojun,ZHAO Da.Clinical Study on KangLaiTe Soft Capsule and Chemotherapy in Treating Ovarian Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1.
[2]倪红,蔡正良.裴正学教授从痰论治乳腺癌术后淋巴水肿验案[J].西部中医药,2013,26(02):54.
　NI Hong,CAI Zhengliang.Effective Cases of Professor Pei Zhengxue Treating Lymphedema after Mammary Cancer Surgery from Phlegm[J].Western Journal of Traditional Chinese Medicine,2013,26(07):54.
[3]高运来.贞芪扶正颗粒配合手术治疗颌面部肿瘤40例临床观察[J].西部中医药,2013,26(03):4.
　GAO Yunlai.Clinical Observation on Surgery and ZhenQi FuZheng Granules in Treating 40 Cases of Maxillo-facial Tumor[J].Western Journal of Traditional Chinese Medicine,2013,26(07):4.
[4]沈世银,周维华,陈丽萍,等.白介素-11联合循证护理对血液病化疗患者口腔黏膜炎疗效的影响[J].西部中医药,2014,27(06):126.
　SHEN Shiyin,ZHOU Weihua,CHEN Liping,et al.Influence of IL-11 and Evidence-based Nursing on Clinical Effects of Oral Mucositis of Blood Disease Patients Undergoing Chemotherapy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):126.
[5]席彩霞,杨国泉,苏安平,等.贞芪益气胶囊联合 GP 方案治疗晚期非小细胞肺癌的临床研究[J].西部中医药,2014,27(09):4.
[6]张芳,孟宪明.培土生金法对气虚痰湿型肺癌化疗减毒增效的临床研究[J].西部中医药,2014,27(10):94.
[7]朱娜,代瑞花,米学丽.护理干预对妇科恶性肿瘤术后化疗患者心理控制源倾向的影响[J].西部中医药,2014,27(10):135.
[8]王丽,何丽娟,朱玉芹.循证护理对乳腺癌化疗患者自尊水平和应对方式的影响[J].西部中医药,2014,27(11):134.
[9]朱竹华,顾菊凤,姚洪芳,等.协同护理模式对胃癌术后化疗患者心理健康和自我护理能力的影响[J].西部中医药,2014,27(12):115.
[10]张晓华,张晓岚△,梁玉荣,等.综合心理干预对乳腺癌化疗患者医学应对方式及生命质量的影响[J].西部中医药,2015,28(07):123.

备注/Memo

备注/Memo:
上海市卫生健康委员会科研课题（202040254）。陈郑（1998—），女，硕士学位。研究方向：乳腺疾病的中西医结合治疗。
更新日期/Last Update: 2026-07-15